ESCALON MEDICAL CORPORATION (NASDAQ: ESMC) "Up 148.72% on Thursday"
Escalon Medical Corp., together with its subsidiaries, engages in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes, hematology, and vascular access. It provides instruments for blood cell counting and blood analysis; and supplies the reagent and other consumable materials needed to operate the instruments. The company also sells diabetic testing products, including DS5 that measures long-term glucose control in diabetic patients; and Hb-Gold, which provides for the in-vitro measurement of certain genetic diseases of the blood. In addition, Escalon Medical Corp. offers equipment for use in the field of human and veterinary hematology. Further, it develops, manufactures, and markets ultrasound systems for diagnostic or biometric applications in ophthalmology, including A-scans, B-scans, high frequency B-scans, and pachymeters. Additionally, the company offers vascular access products, including PD Access and SmartNeedle lines of monitors, and Doppler-guided bare needles and infusion needles that are used to locate desired vessels for access, as well as provides VascuView Visual ultrasound system. It also markets a Color/Fluorescein Angiography digital imaging system for ophthalmology; offers ophthalmic surgical products to vitreoretinal ophthalmic surgeons; distributes intraocular gas products, including C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; provides light sources, fiber optic probes, and illuminated tissue manipulators; and markets viscous fluid transfer systems and related disposable syringe products. Escalon Medical Corp. sells its products through internal sales employees, independent sales representatives, and distributors to medical institutions, teaching institutions, hospitals, and eye surgery centers in the United States and Europe. The company was founded in 1987 and is based in Wayne, Pennsylvania.
COLLABRX INCORPORATED (NASDAQ: CLRX) "Up 37.99% on Thursday"
CollabRx, Inc. (CLRX) is a recognized leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care.
About OTCPicks.com
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily stock alerts go to www.otcpicks.com to sign up.
Disclosure: OTCPicks.com is not currently being compensated by any of the companies covered in this release.
